logo

Preparation of 99mTc-HYNIC-Annexin V

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE

Preparation of 99mTc-HYNIC-Annexin V

LAN Xiao-Li
ZHANG Yong-Xue
Nuclear Science and TechniquesVol.16, No.5pp.299-303Published in print 01 Oct 2005
34900

99mTc-HYNIC-Annexin V was prepared for apoptosis radionuclide imaging in vivo. The expression plasmid of human Annexin V was constructed and expressed in E. coli.. HYNIC was prepared and used as bifunctional chelating agent for 99mTc labeling. The radiochemical purity, radiolabeling yield and stability of 99mTc-HYNIC-Annexin V were studied. The coding sequence of human Annexin V gene was successfully cloned into the expression vector, and highly expressed in E. coli. A protein with a molecular weight of about 36kD could be induced and confirmed by Western Blotting and SDS-PAGE. Annexin V could be labeled with 99mTc using HYNIC, and showed high radiochemical purity of more than 90%. The radiolabeling yield could reach more than 90%. The reaction condition was moderate. It suggested that 99mTc-HYNIC-Annexin V may be a promising agent for apoptosis imaging and clinical application.

Annexin VApoptosis99mTc labelingHYNIC
References
[1] Darzynkiewicz Z. J Cell Biochem, 1995, 58: 151-159
[2] Steller H. Science, 1995, 267: 1445-1449
[3] Thomposon B C. Science, 1995, 267: 1456-1462
[4] van Heerde W L, de Groot P G, Reutelingsperger C P M. Thromb Haemost, 1995, 73: 172-179
[5] Abrams M J, Juweid M, Tenkate C I, et al. J Nucl Med, 1990, 31(12): 2022-2028
[6] Strausberg R L, Feingold E A, Grouse L H, et al. Proc Natl Acad Sci USA, 2002, 99(26): 16899-16903
[7] Takei T, Kuge Y, Zhao S, et al. J Nucl Med, 2004, 45(12): 2083-2087
[8] Kartachova M, Haas R L, Olmos R A, et al. Radiother Oncol, 2004, 72(3): 333-339
[9] Kemerink G J, Liem I H, Hofstra L, et al. J Nucl Med, 2001, 42: 382-387
[10] Kemerink G J, Boersma H H, Thimister P W L, et al. Eur J Nucl Med Mol Imaging, 2001, 28: 1373-1378
[11] Purohit A, Liu S, Casebier D, et al. Bioconjug Chem, 2003, 14(4): 720-727
[12] Verbeke K, Kieffer D, Vanderheyden J L, et al. Nucl Med Biol, 2003, 30: 771-778